% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Xie:284349,
author = {Xie, Kan and Ryan, Devon and Schröder, Susanne and Freund,
Lena and Bonn, Stefan and Zhou, Yu and Ehninger, Dan},
title = {{S}elective vulnerability of the aging cholinergic system
to amyloid pathology revealed by induced {APP}
overexpression.},
journal = {Journal of neuroinflammation},
volume = {23},
number = {1},
issn = {1742-2094},
address = {London},
publisher = {BioMed Central},
reportid = {DZNE-2026-00120},
pages = {39},
year = {2026},
abstract = {Alzheimer's disease (AD) is a progressive neurodegenerative
disorder characterized by amyloid beta (Aβ) accumulation,
tau pathology, and cognitive decline, with aging as the
primary risk factor. To investigate whether age influences
susceptibility to Aβ toxicity, we used a
tetracycline-inducible mouse model expressing a mutant human
APP transgene (APPSweInd) and initiated expression during
either mid-age (6-18 months) or old age (12-24 months).
After one year of transgene activation, we assessed
behavior, amyloid pathology, inflammation, autophagy, and
brain gene expression compared to age-matched controls.
Although APP expression, Aβ deposition, inflammatory
markers, and autophagic flux were comparable between age
groups, aged APP-expressing mice displayed cognitive
impairments, hyperactivity, and motor deficits that were
absent in their younger counterparts. Transcriptomic
analysis revealed selective downregulation of cholinergic
system genes specifically in the aged APP-induced group,
validated at RNA and protein levels. No changes were
observed in markers of other neuronal cell types, indicating
a targeted cholinergic vulnerability. These findings suggest
that age enhances the brain's susceptibility to Aβ
toxicity, particularly affecting the cholinergic system,
rather than amplifying amyloid burden itself. This inducible
model provides a relevant platform to study the interaction
between aging and Aβ pathology and may help identify
age-related factors contributing to AD progression.},
keywords = {Animals / Amyloid beta-Protein Precursor: genetics /
Amyloid beta-Protein Precursor: biosynthesis / Amyloid
beta-Protein Precursor: metabolism / Mice, Transgenic / Mice
/ Aging: pathology / Aging: metabolism / Aging: genetics /
Humans / Brain: pathology / Brain: metabolism / Amyloid
beta-Peptides: metabolism / Alzheimer Disease: pathology /
Alzheimer Disease: metabolism / Alzheimer Disease: genetics
/ Male / Disease Models, Animal / Mice, Inbred C57BL /
Cholinergic Neurons: pathology / Cholinergic Neurons:
metabolism / Aging (Other) / Alzheimer´s disease (Other) /
Aβ (Other) / Cholinergic system (Other) / Neurodegeneration
(Other) / Amyloid beta-Protein Precursor (NLM Chemicals) /
Amyloid beta-Peptides (NLM Chemicals)},
cin = {AG Ehninger},
ddc = {610},
cid = {I:(DE-2719)1013005},
pnm = {352 - Disease Mechanisms (POF4-352)},
pid = {G:(DE-HGF)POF4-352},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:41495755},
pmc = {pmc:PMC12849525},
doi = {10.1186/s12974-025-03682-2},
url = {https://pub.dzne.de/record/284349},
}